nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—Paget's disease of bone—ankylosing spondylitis	0.506	0.522	CtDrD
Alendronate—osteoporosis—ankylosing spondylitis	0.463	0.478	CtDrD
Alendronate—Impaired healing—Prednisolone—ankylosing spondylitis	0.000784	0.0256	CcSEcCtD
Alendronate—Oesophageal ulcer—Betamethasone—ankylosing spondylitis	0.000776	0.0253	CcSEcCtD
Alendronate—Oesophageal ulcer—Dexamethasone—ankylosing spondylitis	0.000776	0.0253	CcSEcCtD
Alendronate—Leukaemia—Methotrexate—ankylosing spondylitis	0.000765	0.025	CcSEcCtD
Alendronate—Impaired healing—Triamcinolone—ankylosing spondylitis	0.000721	0.0236	CcSEcCtD
Alendronate—Impaired healing—Methylprednisolone—ankylosing spondylitis	0.000719	0.0235	CcSEcCtD
Alendronate—Oesophageal ulcer—Prednisone—ankylosing spondylitis	0.000675	0.0221	CcSEcCtD
Alendronate—Impaired healing—Dexamethasone—ankylosing spondylitis	0.000654	0.0214	CcSEcCtD
Alendronate—Impaired healing—Betamethasone—ankylosing spondylitis	0.000654	0.0214	CcSEcCtD
Alendronate—Impaired healing—Prednisone—ankylosing spondylitis	0.00057	0.0186	CcSEcCtD
Alendronate—Lymphopenia—Prednisone—ankylosing spondylitis	0.000482	0.0157	CcSEcCtD
Alendronate—Impaired healing—Methotrexate—ankylosing spondylitis	0.000476	0.0156	CcSEcCtD
Alendronate—Hypercalcaemia—Methylprednisolone—ankylosing spondylitis	0.000448	0.0146	CcSEcCtD
Alendronate—Ulcer—Triamcinolone—ankylosing spondylitis	0.00033	0.0108	CcSEcCtD
Alendronate—Ulcer—Dexamethasone—ankylosing spondylitis	0.000299	0.00977	CcSEcCtD
Alendronate—Ulcer—Betamethasone—ankylosing spondylitis	0.000299	0.00977	CcSEcCtD
Alendronate—Oesophagitis—Methylprednisolone—ankylosing spondylitis	0.000284	0.00929	CcSEcCtD
Alendronate—Ulcer—Prednisone—ankylosing spondylitis	0.000261	0.00851	CcSEcCtD
Alendronate—Oesophagitis—Dexamethasone—ankylosing spondylitis	0.000259	0.00845	CcSEcCtD
Alendronate—Oesophagitis—Betamethasone—ankylosing spondylitis	0.000259	0.00845	CcSEcCtD
Alendronate—Dry skin—Prednisolone—ankylosing spondylitis	0.000226	0.00737	CcSEcCtD
Alendronate—Oesophagitis—Prednisone—ankylosing spondylitis	0.000225	0.00736	CcSEcCtD
Alendronate—Ulcer—Methotrexate—ankylosing spondylitis	0.000218	0.00711	CcSEcCtD
Alendronate—Abdominal distension—Prednisolone—ankylosing spondylitis	0.000214	0.007	CcSEcCtD
Alendronate—Melaena—Methotrexate—ankylosing spondylitis	0.000201	0.00657	CcSEcCtD
Alendronate—Abdominal distension—Triamcinolone—ankylosing spondylitis	0.000197	0.00644	CcSEcCtD
Alendronate—Abdominal distension—Methylprednisolone—ankylosing spondylitis	0.000197	0.00642	CcSEcCtD
Alendronate—Asthma—Triamcinolone—ankylosing spondylitis	0.000196	0.00639	CcSEcCtD
Alendronate—Dry skin—Dexamethasone—ankylosing spondylitis	0.000188	0.00615	CcSEcCtD
Alendronate—Dry skin—Betamethasone—ankylosing spondylitis	0.000188	0.00615	CcSEcCtD
Alendronate—Haemoglobin—Prednisolone—ankylosing spondylitis	0.000171	0.00559	CcSEcCtD
Alendronate—Haemorrhage—Prednisolone—ankylosing spondylitis	0.00017	0.00556	CcSEcCtD
Alendronate—Photosensitivity—Methotrexate—ankylosing spondylitis	0.00017	0.00556	CcSEcCtD
Alendronate—Dry skin—Prednisone—ankylosing spondylitis	0.000164	0.00536	CcSEcCtD
Alendronate—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.000157	0.00514	CcSEcCtD
Alendronate—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000157	0.00513	CcSEcCtD
Alendronate—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000157	0.00512	CcSEcCtD
Alendronate—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000156	0.00511	CcSEcCtD
Alendronate—Abdominal distension—Prednisone—ankylosing spondylitis	0.000156	0.00509	CcSEcCtD
Alendronate—Erythema—Prednisolone—ankylosing spondylitis	0.000148	0.00484	CcSEcCtD
Alendronate—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000143	0.00467	CcSEcCtD
Alendronate—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000143	0.00467	CcSEcCtD
Alendronate—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000142	0.00464	CcSEcCtD
Alendronate—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000142	0.00464	CcSEcCtD
Alendronate—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000138	0.00449	CcSEcCtD
Alendronate—Erythema—Triamcinolone—ankylosing spondylitis	0.000136	0.00445	CcSEcCtD
Alendronate—Erythema—Methylprednisolone—ankylosing spondylitis	0.000136	0.00444	CcSEcCtD
Alendronate—Angioedema—Prednisolone—ankylosing spondylitis	0.000135	0.00443	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000135	0.0044	CcSEcCtD
Alendronate—Malaise—Prednisolone—ankylosing spondylitis	0.000134	0.00437	CcSEcCtD
Alendronate—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000134	0.00436	CcSEcCtD
Alendronate—Vertigo—Prednisolone—ankylosing spondylitis	0.000133	0.00435	CcSEcCtD
Alendronate—Asthma—Methotrexate—ankylosing spondylitis	0.000129	0.00422	CcSEcCtD
Alendronate—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000126	0.00413	CcSEcCtD
Alendronate—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000126	0.00412	CcSEcCtD
Alendronate—Alopecia—Dexamethasone—ankylosing spondylitis	0.000126	0.0041	CcSEcCtD
Alendronate—Alopecia—Betamethasone—ankylosing spondylitis	0.000126	0.0041	CcSEcCtD
Alendronate—Discomfort—Prednisolone—ankylosing spondylitis	0.000125	0.00407	CcSEcCtD
Alendronate—Angioedema—Triamcinolone—ankylosing spondylitis	0.000125	0.00407	CcSEcCtD
Alendronate—Haemoglobin—Prednisone—ankylosing spondylitis	0.000124	0.00406	CcSEcCtD
Alendronate—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000124	0.00406	CcSEcCtD
Alendronate—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000124	0.00405	CcSEcCtD
Alendronate—Haemorrhage—Prednisone—ankylosing spondylitis	0.000124	0.00404	CcSEcCtD
Alendronate—Erythema—Dexamethasone—ankylosing spondylitis	0.000124	0.00404	CcSEcCtD
Alendronate—Erythema—Betamethasone—ankylosing spondylitis	0.000124	0.00404	CcSEcCtD
Alendronate—Malaise—Triamcinolone—ankylosing spondylitis	0.000123	0.00402	CcSEcCtD
Alendronate—Malaise—Methylprednisolone—ankylosing spondylitis	0.000123	0.00401	CcSEcCtD
Alendronate—Vertigo—Triamcinolone—ankylosing spondylitis	0.000122	0.004	CcSEcCtD
Alendronate—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000122	0.00399	CcSEcCtD
Alendronate—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000118	0.00385	CcSEcCtD
Alendronate—Myalgia—Triamcinolone—ankylosing spondylitis	0.000116	0.00379	CcSEcCtD
Alendronate—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000116	0.00378	CcSEcCtD
Alendronate—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000115	0.00375	CcSEcCtD
Alendronate—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000115	0.00375	CcSEcCtD
Alendronate—Discomfort—Triamcinolone—ankylosing spondylitis	0.000115	0.00375	CcSEcCtD
Alendronate—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000114	0.00374	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000114	0.00373	CcSEcCtD
Alendronate—Angioedema—Betamethasone—ankylosing spondylitis	0.000113	0.00369	CcSEcCtD
Alendronate—Angioedema—Dexamethasone—ankylosing spondylitis	0.000113	0.00369	CcSEcCtD
Alendronate—Stomatitis—Methotrexate—ankylosing spondylitis	0.000112	0.00367	CcSEcCtD
Alendronate—Malaise—Betamethasone—ankylosing spondylitis	0.000112	0.00364	CcSEcCtD
Alendronate—Malaise—Dexamethasone—ankylosing spondylitis	0.000112	0.00364	CcSEcCtD
Alendronate—Vertigo—Betamethasone—ankylosing spondylitis	0.000111	0.00363	CcSEcCtD
Alendronate—Vertigo—Dexamethasone—ankylosing spondylitis	0.000111	0.00363	CcSEcCtD
Alendronate—Infection—Triamcinolone—ankylosing spondylitis	0.000111	0.00361	CcSEcCtD
Alendronate—Infection—Methylprednisolone—ankylosing spondylitis	0.00011	0.0036	CcSEcCtD
Alendronate—Alopecia—Prednisone—ankylosing spondylitis	0.000109	0.00357	CcSEcCtD
Alendronate—Erythema—Prednisone—ankylosing spondylitis	0.000108	0.00352	CcSEcCtD
Alendronate—Myalgia—Dexamethasone—ankylosing spondylitis	0.000105	0.00344	CcSEcCtD
Alendronate—Myalgia—Betamethasone—ankylosing spondylitis	0.000105	0.00344	CcSEcCtD
Alendronate—Discomfort—Dexamethasone—ankylosing spondylitis	0.000104	0.0034	CcSEcCtD
Alendronate—Discomfort—Betamethasone—ankylosing spondylitis	0.000104	0.0034	CcSEcCtD
Alendronate—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000104	0.0034	CcSEcCtD
Alendronate—Pain—Prednisolone—ankylosing spondylitis	0.000103	0.00338	CcSEcCtD
Alendronate—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000103	0.00338	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000101	0.00331	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000101	0.0033	CcSEcCtD
Alendronate—Infection—Betamethasone—ankylosing spondylitis	0.0001	0.00328	CcSEcCtD
Alendronate—Infection—Dexamethasone—ankylosing spondylitis	0.0001	0.00328	CcSEcCtD
Alendronate—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.0001	0.00327	CcSEcCtD
Alendronate—Feeling abnormal—Prednisolone—ankylosing spondylitis	9.97e-05	0.00326	CcSEcCtD
Alendronate—Anaemia—Prednisone—ankylosing spondylitis	9.96e-05	0.00325	CcSEcCtD
Alendronate—Angioedema—Prednisone—ankylosing spondylitis	9.84e-05	0.00322	CcSEcCtD
Alendronate—Dyspepsia—Triamcinolone—ankylosing spondylitis	9.79e-05	0.0032	CcSEcCtD
Alendronate—Erythema multiforme—Methotrexate—ankylosing spondylitis	9.78e-05	0.00319	CcSEcCtD
Alendronate—Dyspepsia—Methylprednisolone—ankylosing spondylitis	9.77e-05	0.00319	CcSEcCtD
Alendronate—Malaise—Prednisone—ankylosing spondylitis	9.71e-05	0.00317	CcSEcCtD
Alendronate—Vertigo—Prednisone—ankylosing spondylitis	9.68e-05	0.00316	CcSEcCtD
Alendronate—Urticaria—Prednisolone—ankylosing spondylitis	9.61e-05	0.00314	CcSEcCtD
Alendronate—Pain—Triamcinolone—ankylosing spondylitis	9.51e-05	0.00311	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	9.2e-05	0.00301	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	9.2e-05	0.00301	CcSEcCtD
Alendronate—Myalgia—Prednisone—ankylosing spondylitis	9.17e-05	0.003	CcSEcCtD
Alendronate—Feeling abnormal—Triamcinolone—ankylosing spondylitis	9.17e-05	0.003	CcSEcCtD
Alendronate—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	9.15e-05	0.00299	CcSEcCtD
Alendronate—Alopecia—Methotrexate—ankylosing spondylitis	9.14e-05	0.00299	CcSEcCtD
Alendronate—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	9.08e-05	0.00297	CcSEcCtD
Alendronate—Discomfort—Prednisone—ankylosing spondylitis	9.06e-05	0.00296	CcSEcCtD
Alendronate—Erythema—Methotrexate—ankylosing spondylitis	9e-05	0.00294	CcSEcCtD
Alendronate—Hypersensitivity—Prednisolone—ankylosing spondylitis	8.91e-05	0.00291	CcSEcCtD
Alendronate—Dyspepsia—Dexamethasone—ankylosing spondylitis	8.89e-05	0.0029	CcSEcCtD
Alendronate—Dyspepsia—Betamethasone—ankylosing spondylitis	8.89e-05	0.0029	CcSEcCtD
Alendronate—Urticaria—Triamcinolone—ankylosing spondylitis	8.84e-05	0.00289	CcSEcCtD
Alendronate—Urticaria—Methylprednisolone—ankylosing spondylitis	8.82e-05	0.00288	CcSEcCtD
Alendronate—Dysgeusia—Methotrexate—ankylosing spondylitis	8.82e-05	0.00288	CcSEcCtD
Alendronate—Body temperature increased—Triamcinolone—ankylosing spondylitis	8.8e-05	0.00287	CcSEcCtD
Alendronate—Abdominal pain—Methylprednisolone—ankylosing spondylitis	8.78e-05	0.00287	CcSEcCtD
Alendronate—Infection—Prednisone—ankylosing spondylitis	8.73e-05	0.00285	CcSEcCtD
Alendronate—Pain—Dexamethasone—ankylosing spondylitis	8.63e-05	0.00282	CcSEcCtD
Alendronate—Pain—Betamethasone—ankylosing spondylitis	8.63e-05	0.00282	CcSEcCtD
Alendronate—Ill-defined disorder—Methotrexate—ankylosing spondylitis	8.35e-05	0.00273	CcSEcCtD
Alendronate—Anaemia—Methotrexate—ankylosing spondylitis	8.32e-05	0.00272	CcSEcCtD
Alendronate—Feeling abnormal—Dexamethasone—ankylosing spondylitis	8.32e-05	0.00272	CcSEcCtD
Alendronate—Feeling abnormal—Betamethasone—ankylosing spondylitis	8.32e-05	0.00272	CcSEcCtD
Alendronate—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	8.26e-05	0.0027	CcSEcCtD
Alendronate—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	8.26e-05	0.0027	CcSEcCtD
Alendronate—Hypersensitivity—Triamcinolone—ankylosing spondylitis	8.2e-05	0.00268	CcSEcCtD
Alendronate—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	8.18e-05	0.00267	CcSEcCtD
Alendronate—Malaise—Methotrexate—ankylosing spondylitis	8.12e-05	0.00265	CcSEcCtD
Alendronate—Vertigo—Methotrexate—ankylosing spondylitis	8.09e-05	0.00264	CcSEcCtD
Alendronate—Urticaria—Dexamethasone—ankylosing spondylitis	8.02e-05	0.00262	CcSEcCtD
Alendronate—Urticaria—Betamethasone—ankylosing spondylitis	8.02e-05	0.00262	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	8.01e-05	0.00262	CcSEcCtD
Alendronate—Dizziness—Prednisolone—ankylosing spondylitis	8e-05	0.00261	CcSEcCtD
Alendronate—Asthenia—Triamcinolone—ankylosing spondylitis	7.98e-05	0.00261	CcSEcCtD
Alendronate—Abdominal pain—Dexamethasone—ankylosing spondylitis	7.98e-05	0.00261	CcSEcCtD
Alendronate—Abdominal pain—Betamethasone—ankylosing spondylitis	7.98e-05	0.00261	CcSEcCtD
Alendronate—Body temperature increased—Betamethasone—ankylosing spondylitis	7.98e-05	0.00261	CcSEcCtD
Alendronate—Body temperature increased—Dexamethasone—ankylosing spondylitis	7.98e-05	0.00261	CcSEcCtD
Alendronate—Asthenia—Methylprednisolone—ankylosing spondylitis	7.97e-05	0.0026	CcSEcCtD
Alendronate—Pruritus—Triamcinolone—ankylosing spondylitis	7.87e-05	0.00257	CcSEcCtD
Alendronate—Pruritus—Methylprednisolone—ankylosing spondylitis	7.85e-05	0.00257	CcSEcCtD
Alendronate—Dyspepsia—Prednisone—ankylosing spondylitis	7.74e-05	0.00253	CcSEcCtD
Alendronate—Myalgia—Methotrexate—ankylosing spondylitis	7.66e-05	0.0025	CcSEcCtD
Alendronate—Chest pain—Methotrexate—ankylosing spondylitis	7.66e-05	0.0025	CcSEcCtD
Alendronate—Rash—Prednisolone—ankylosing spondylitis	7.63e-05	0.00249	CcSEcCtD
Alendronate—Dermatitis—Prednisolone—ankylosing spondylitis	7.62e-05	0.00249	CcSEcCtD
Alendronate—Diarrhoea—Methylprednisolone—ankylosing spondylitis	7.6e-05	0.00248	CcSEcCtD
Alendronate—Headache—Prednisolone—ankylosing spondylitis	7.58e-05	0.00248	CcSEcCtD
Alendronate—Discomfort—Methotrexate—ankylosing spondylitis	7.57e-05	0.00247	CcSEcCtD
Alendronate—Constipation—Prednisone—ankylosing spondylitis	7.52e-05	0.00246	CcSEcCtD
Alendronate—Dizziness—Triamcinolone—ankylosing spondylitis	7.36e-05	0.0024	CcSEcCtD
Alendronate—Dizziness—Methylprednisolone—ankylosing spondylitis	7.34e-05	0.0024	CcSEcCtD
Alendronate—Infection—Methotrexate—ankylosing spondylitis	7.3e-05	0.00238	CcSEcCtD
Alendronate—Feeling abnormal—Prednisone—ankylosing spondylitis	7.24e-05	0.00237	CcSEcCtD
Alendronate—Asthenia—Dexamethasone—ankylosing spondylitis	7.24e-05	0.00237	CcSEcCtD
Alendronate—Asthenia—Betamethasone—ankylosing spondylitis	7.24e-05	0.00237	CcSEcCtD
Alendronate—Gastrointestinal pain—Prednisone—ankylosing spondylitis	7.19e-05	0.00235	CcSEcCtD
Alendronate—Nausea—Prednisolone—ankylosing spondylitis	7.19e-05	0.00235	CcSEcCtD
Alendronate—Pruritus—Betamethasone—ankylosing spondylitis	7.14e-05	0.00233	CcSEcCtD
Alendronate—Pruritus—Dexamethasone—ankylosing spondylitis	7.14e-05	0.00233	CcSEcCtD
Alendronate—Vomiting—Triamcinolone—ankylosing spondylitis	7.07e-05	0.00231	CcSEcCtD
Alendronate—Vomiting—Methylprednisolone—ankylosing spondylitis	7.06e-05	0.00231	CcSEcCtD
Alendronate—Rash—Triamcinolone—ankylosing spondylitis	7.02e-05	0.00229	CcSEcCtD
Alendronate—Dermatitis—Triamcinolone—ankylosing spondylitis	7.01e-05	0.00229	CcSEcCtD
Alendronate—Rash—Methylprednisolone—ankylosing spondylitis	7e-05	0.00229	CcSEcCtD
Alendronate—Dermatitis—Methylprednisolone—ankylosing spondylitis	6.99e-05	0.00228	CcSEcCtD
Alendronate—Urticaria—Prednisone—ankylosing spondylitis	6.98e-05	0.00228	CcSEcCtD
Alendronate—Headache—Triamcinolone—ankylosing spondylitis	6.97e-05	0.00228	CcSEcCtD
Alendronate—Headache—Methylprednisolone—ankylosing spondylitis	6.95e-05	0.00227	CcSEcCtD
Alendronate—Body temperature increased—Prednisone—ankylosing spondylitis	6.95e-05	0.00227	CcSEcCtD
Alendronate—Abdominal pain—Prednisone—ankylosing spondylitis	6.95e-05	0.00227	CcSEcCtD
Alendronate—Diarrhoea—Dexamethasone—ankylosing spondylitis	6.91e-05	0.00226	CcSEcCtD
Alendronate—Diarrhoea—Betamethasone—ankylosing spondylitis	6.91e-05	0.00226	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	6.69e-05	0.00219	CcSEcCtD
Alendronate—Dizziness—Betamethasone—ankylosing spondylitis	6.68e-05	0.00218	CcSEcCtD
Alendronate—Dizziness—Dexamethasone—ankylosing spondylitis	6.68e-05	0.00218	CcSEcCtD
Alendronate—Nausea—Triamcinolone—ankylosing spondylitis	6.61e-05	0.00216	CcSEcCtD
Alendronate—Nausea—Methylprednisolone—ankylosing spondylitis	6.59e-05	0.00215	CcSEcCtD
Alendronate—Hypersensitivity—Prednisone—ankylosing spondylitis	6.48e-05	0.00212	CcSEcCtD
Alendronate—Dyspepsia—Methotrexate—ankylosing spondylitis	6.47e-05	0.00211	CcSEcCtD
Alendronate—Vomiting—Dexamethasone—ankylosing spondylitis	6.42e-05	0.0021	CcSEcCtD
Alendronate—Vomiting—Betamethasone—ankylosing spondylitis	6.42e-05	0.0021	CcSEcCtD
Alendronate—Rash—Dexamethasone—ankylosing spondylitis	6.37e-05	0.00208	CcSEcCtD
Alendronate—Rash—Betamethasone—ankylosing spondylitis	6.37e-05	0.00208	CcSEcCtD
Alendronate—Dermatitis—Betamethasone—ankylosing spondylitis	6.36e-05	0.00208	CcSEcCtD
Alendronate—Dermatitis—Dexamethasone—ankylosing spondylitis	6.36e-05	0.00208	CcSEcCtD
Alendronate—Headache—Dexamethasone—ankylosing spondylitis	6.32e-05	0.00207	CcSEcCtD
Alendronate—Headache—Betamethasone—ankylosing spondylitis	6.32e-05	0.00207	CcSEcCtD
Alendronate—Asthenia—Prednisone—ankylosing spondylitis	6.31e-05	0.00206	CcSEcCtD
Alendronate—Pain—Methotrexate—ankylosing spondylitis	6.28e-05	0.00205	CcSEcCtD
Alendronate—Pruritus—Prednisone—ankylosing spondylitis	6.22e-05	0.00203	CcSEcCtD
Alendronate—Feeling abnormal—Methotrexate—ankylosing spondylitis	6.05e-05	0.00198	CcSEcCtD
Alendronate—Diarrhoea—Prednisone—ankylosing spondylitis	6.02e-05	0.00197	CcSEcCtD
Alendronate—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	6.01e-05	0.00196	CcSEcCtD
Alendronate—Nausea—Dexamethasone—ankylosing spondylitis	6e-05	0.00196	CcSEcCtD
Alendronate—Nausea—Betamethasone—ankylosing spondylitis	6e-05	0.00196	CcSEcCtD
Alendronate—Urticaria—Methotrexate—ankylosing spondylitis	5.84e-05	0.00191	CcSEcCtD
Alendronate—Dizziness—Prednisone—ankylosing spondylitis	5.81e-05	0.0019	CcSEcCtD
Alendronate—Abdominal pain—Methotrexate—ankylosing spondylitis	5.81e-05	0.0019	CcSEcCtD
Alendronate—Body temperature increased—Methotrexate—ankylosing spondylitis	5.81e-05	0.0019	CcSEcCtD
Alendronate—Vomiting—Prednisone—ankylosing spondylitis	5.59e-05	0.00183	CcSEcCtD
Alendronate—Rash—Prednisone—ankylosing spondylitis	5.54e-05	0.00181	CcSEcCtD
Alendronate—Dermatitis—Prednisone—ankylosing spondylitis	5.54e-05	0.00181	CcSEcCtD
Alendronate—Headache—Prednisone—ankylosing spondylitis	5.51e-05	0.0018	CcSEcCtD
Alendronate—Hypersensitivity—Methotrexate—ankylosing spondylitis	5.41e-05	0.00177	CcSEcCtD
Alendronate—Asthenia—Methotrexate—ankylosing spondylitis	5.27e-05	0.00172	CcSEcCtD
Alendronate—Nausea—Prednisone—ankylosing spondylitis	5.22e-05	0.00171	CcSEcCtD
Alendronate—Pruritus—Methotrexate—ankylosing spondylitis	5.2e-05	0.0017	CcSEcCtD
Alendronate—Diarrhoea—Methotrexate—ankylosing spondylitis	5.03e-05	0.00164	CcSEcCtD
Alendronate—Dizziness—Methotrexate—ankylosing spondylitis	4.86e-05	0.00159	CcSEcCtD
Alendronate—Vomiting—Methotrexate—ankylosing spondylitis	4.67e-05	0.00153	CcSEcCtD
Alendronate—Rash—Methotrexate—ankylosing spondylitis	4.63e-05	0.00151	CcSEcCtD
Alendronate—Dermatitis—Methotrexate—ankylosing spondylitis	4.63e-05	0.00151	CcSEcCtD
Alendronate—Headache—Methotrexate—ankylosing spondylitis	4.6e-05	0.0015	CcSEcCtD
Alendronate—Nausea—Methotrexate—ankylosing spondylitis	4.36e-05	0.00143	CcSEcCtD
